missing translation for 'onlineSavingsMsg'
Learn More
Learn More
HeLa S3 (human cervical epithlioid carcinoma) Nuclear extract lysate, Non-denatured; Abnova
Marca: Abnova L013V4.50ug
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
Western Blotting, Immunoprecipitation
Specifica
| Immunoprecipitation, Western Blot | |
| Nuclear extract cell lysate (non-denatured) | |
| Nuclear extract was prepared by using a modified protocol of Dignam et al. Cells were Harvested and homogenized in Buffer A, and then centrifugated at 25,000 g for 20 minutes to remove cytoplasm and pellet the nuclei. The pellet was re-suspended in Buffer C, and then the suspensions were centrifuged to collect nuclear extract. The supernatant was dialyzed against Buffer D. The dialysate was then centrifuged, divided into aliquots, and stored at -80°C. The protein concentration was determined by the method of Bradford (Bio-Rad protein assay, microplate standard assay). The lysate was adjusted to 2 mg/ml. | |
| 50 μg | |
| Human | |
| Store at -80°C. Aliquot to avoid repeated freezing and thawing. |
| Cervix, Adenocarcinoma | |
| Buffer A: 10mM HEPES pH 7.9, 1.5mM MgCl2, 10mM KCl, 0.5 mM DTT. Buffer C: 20mM HEPES pH 7.9, 25%(v/v) Glycerol , 0.42M NaCl , 1.5mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT & 0.5 mM PMSF. Buffer D : 20mM HEPES pH 7.9, 20%(v/v) glycerol, 50mM KCl, 0.2 mM EDTA, 0.5 mM DTT & 0.5 mM PMSF. | |
| 12.5% SDS-PAGE Stained with Coomassie Blue. | |
| In Buffer D. | |
| 2.5 mg/mL |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto